openPR Logo
Press release

Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Opportunity Analysis, 2018-2026

08-17-2018 02:45 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Cytomegalovirus (CMV) Infection Treatment and Diagnosis

Cytomegalovirus (CMV) is a virus that belongs to herpes virus family that remain dormant in the human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable disease that spreads through body fluids such as saliva, blood, urine, semen, and breast milk. Presence of CMV infection can be detected by various testing methods based on which the global cytomegalovirus infection treatment and diagnosis market can be analyzed:

-Serologic test
-Polymerase chain reaction (PCR) test

Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/167

CMV diagnosis is very critical in pregnant women and immunocompromised individuals. Enzyme-linked immunoassay test is the most widely used serologic testing for CMV infection in laboratories. Besides, PCR technique is also widely implemented for samples of saliva, and urine. Awareness about the infection is essential as most of the cases go undiagnosed at early stages as the disease is asymptomatic.

Cytomegalovirus infection market: Treatment approach

People diagnosed with high risk of CMV infection may be given anti-viral medications to prevent the disease to get in to active stage. There is no cure available for treating the CMV infection. Ganciclovir, Val ganciclovir, Cidofovir, Valacyclovir and Foscarnet are few major anti-viral medications prescribed. In some cases, CMV immune globulin contains antibodies (proteins) may be prescribed to prevent CMV infection. There are certain products in pipeline which includes Cytovir CMV, Letermovir, CytoTect CP 70, Brincidofovir and ASP0113, commercialization of which is expected to fuel the global CMV infection treatment and diagnosis market growth in the near future.

Vital statistics for the global cytomegalovirus infection treatment and diagnosis market

Besides, diagnosis of new CMV cases would be a propelling factor for global cytomegalovirus infection treatment and diagnosis market. The Public Health Agency of Canada estimates that 40%-100% of the global population have CMV antibody present in their body. Immunocompromised patients (HIV, organ transplant), premature infants, newborns and with congenital CMV are at high risk of developing serious illness with CMV infection.

According to the Centers for Disease Control and Prevention (CDC), one in every 150 infants are born with congenital cytomegalovirus (CMV) infection in the U.S. However, only one in five infants infected with CMV have long term health problems. Prevailing infection rates and demand for effective treatment therapies would be thrusting the cytomegalovirus infection treatment and diagnosis market growth.

CMV infection treatment and diagnosis market: Regional overview

Early diagnosis practices would drive the global cytomegalovirus infection treatment and diagnosis market in developed regions such as North America and Europe, where accessibility to advanced diagnostic and treatment facilities is high compared to the emerging economies. For market players in the diagnosis and treatment of CMV infection, ensuring accessibility and healthcare investment in emerging nations would be critical to generate better return on investments.

Table of Content (ToC) at a glance @ https://www.coherentmarketinsights.com/ongoing-insight/toc/167

Some of the major players in the global cytomegalovirus infection treatment and diagnosis market are Merck & Co. Inc., Cell Medical Ltd., Chimerix, Inc., Affymetrix, Inc., Abbott Laboratories, Inc., Becton, Dickinson and Company, Johnson & Johnson, Bio-Rad Laboratories, Inc., and F. Hoffmann-La Roche Ltd.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Opportunity Analysis, 2018-2026 here

News-ID: 1185936 • Views:

More Releases from Coherent Market Insights

Poppy Seeds Market 2032 Industry Overview, Evolution Growth Rate and Future Forecasts 2025-2032
Poppy Seeds Market 2032 Industry Overview, Evolution Growth Rate and Future Fore …
The Poppy Seeds market is estimated to be valued at USD 341.3 Mn in 2025 and is expected to reach USD 506.8 Mn by 2032, growing at a compound annual growth rate CAGR of 5.8% from 2025 to 2032. ➤ The latest study, of the global Poppy Seeds Market presents an in-depth evaluation of current market dynamics, key players, regional trends, market segments, applications, and growth opportunities, with forecasts extending from
Global Supply Chain Security Market Size 2025 Emerging Demands, Share, Trends, Futuristic Opportunity, Share and Forecast To 2032
Global Supply Chain Security Market Size 2025 Emerging Demands, Share, Trends, F …
The Global Supply Chain Security Market is estimated to be valued at USD 2.64 Bn in 2025 and is expected to reach USD 5.62 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2025 to 2032. The latest research study released by Coherent Market Insights on "Supply Chain Security Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a
Global Mobile Cloud Market Size 2025 Emerging Demands, Share, Trends, Futuristic Opportunity, Share and Forecast To 2032
Global Mobile Cloud Market Size 2025 Emerging Demands, Share, Trends, Futuristic …
The Global Mobile Cloud Market is estimated to be valued at USD 72.43 Bn in 2025 and is expected to reach USD 284.74 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 21.6% from 2025 to 2032. The latest research study released by Coherent Market Insights on "Mobile Cloud Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective
Vendor Management Systems Market Share & Growth 2025: Investment Opportunities and Industry Forecast | Google, Amazon Web Services, Microsoft Azure
Vendor Management Systems Market Share & Growth 2025: Investment Opportunities a …
The Global Vendor Management Systems Market is estimated to be valued at USD 10.42 Bn in 2025 and is expected to reach USD 20.69 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 10.30% from 2025 to 2032. The latest research study released by Coherent Market Insights on "Vendor Management Systems Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a

All 5 Releases


More Releases for CMV

Cytomegalovirus (CMV) Infections Market Massive Growth opportunity Ahead
Introduction Cytomegalovirus (CMV) is a common herpesvirus that affects people worldwide, often remaining latent in the body and reactivating under immunocompromised conditions. While typically asymptomatic in healthy individuals, CMV can cause severe complications in newborns, transplant recipients, and immunocompromised patients, making it a significant global healthcare burden. With increasing awareness, advances in antiviral therapies, vaccines under development, and transplant-related CMV management, the CMV infections market is experiencing strong growth. The integration of
Cytomegalovirus (CMV) Vaccine Market | Exploring Current Trends and Growth Statu …
Cytomegalovirus (CMV) Vaccine Market Outlook and Investment Analysis What is the current outlook for the Cytomegalovirus (CMV) vaccine market? The CMV vaccine market is seeing positive growth due to the increasing prevalence of CMV infections globally, particularly in immunocompromised populations such as organ transplant recipients and HIV patients. Moreover, the growing awareness of CMV's impact on newborns has contributed to the push for preventive vaccines. A few vaccines are in advanced clinical
Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026
Cytomegalovirus (CMV) is a common virus that occurs widely among the population. In the U.S., 50%-85% of adults have been infected with cytomegalovirus (CMV). Most people who are infected with the virus do not experience any significant symptoms or health problems. CMV testing involves either a measurement of cytomegalovirus antibodies, immune proteins produced in response to CMV exposure, or the detection of the virus itself. CMV is found in many
Global Commercial Cooking Device Market Forecast 2018-2025 CMV Sharper Finish, Q …
Market study on Global Commercial Cooking Device 2018 Research Report presents a professional and complete analysis of Global Commercial Cooking Device Market on the current market situation. Report provides a general overview of the Commercial Cooking Device industry 2018 including definitions, classifications, Commercial Cooking Device market analysis, a wide range of applications and Commercial Cooking Device industry chain structure. The 2018's report on Commercial Cooking Device industry offers the global
Cytomegalovirus (CMV) Market: Size, Status, Opportunity Analysis and Forecasts t …
A new independent 162 page research with title 'Cytomegalovirus (CMV): Opportunity Analysis and Forecasts to 2027' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions like North America, Europe or Asia and important players/vendors such as Atara Bio, Biotest AG, Helocyte, Merck & Co., Novartis, Shire, ViraCyte With n-number of tables and figures examining the Cytomegalovirus (CMV) Market, the research gives
Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market - Global Industry …
Cytomegalovirus (CMV) is a virus that belongs to herpesvirus family that remain dormant in the human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable disease that spreads through body fluids such as saliva, blood, urine, semen, and breast milk. Presence of CMV infection can be detected by various testing methods based on which the global cytomegalovirus infection treatment and diagnosis market can be